SOL [ReneSola] 6-K: (Original Filing)
[]
[] []
[ReneSola Ltd Announces Fourth Quarter and Full Year 2013 Results JIASHAN, China, March 24, 2014 Fourth Quarter 2013 Financial and Operating Highlights · Total solar module shipments were 505.3 MW, representing an increase of 9.2% from Q3 2013. Total solar wafer and module shipments in Q4 2013 were 784.1 megawatts (“MW”), representing a decrease of 7.9% from 851.0 MW in] []
[ReneSola Ltd Announces Fourth Quarter and Full Year 2013 Results JIASHAN, China, March 24, 2014 Fourth Quarter 2013 Financial and Operating Highlights · Total solar module shipments were 505.3 MW, representing an increase of 9.2% from Q3 2013. Total solar wafer and module shipments in Q4 2013 were 784.1 megawatts (“MW”), representing a decrease of 7.9% from 851.0 MW in] []
[58.com Announces Proposed Primary and Secondary Offering of American Depositary Shares The Company intends to grant to the underwriters a 30-day option to purchase up to 1,200,000 additional ADSs. The Company will not receive any proceeds from the sale of the ADSs by the selling shareholders. BEIJING, CHINA, March 24, 2014 -- 58.com Inc. (NYSE: WUBA) (the “Company”) today announced] []
[CNOOC Limited]
[Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine — -Preclinical development completed for H7N9 vaccine candidates that addresses significant BEIJING, January 29, 2014—Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration(CFDA) to commence human clinical trials for] [Sinovac’s EV71 Vaccine Phase III Clinical Trial Results Published in New — Study shows vaccine provides protection against EV71-associated hand, foot and mouth th The New England Journal of Medicine BEIJING, Feb. 26, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Phase III clinical trial results for its proprietary] [Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 BEIJING, March 12, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014] [Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results - Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December] []
[E-House and Tencent Announce Tencents Strategic Investment in Leju SHANGHAI/SHENZHEN, China, March 21, 2014 E-House (China) Holdings Limited (E-House)(NYSE: EJ), a leading real estate services company in China, Leju Holdings Limited (Leju), a wholly-owned subsidiary of E-House and a leading provider of real estate online services, and Tencent Holdings Limited (Tencent, SEHK stock code: 00700), a leading provider of] [E-HOUSE (CHINA) HOLDINGS LIMITED Qiushi Building, 11/F No.383 Guangyan Road, Zhabei District Shanghai 200072 Peoples Republic of China Form 20-F x Form 40-F o o o E-House (China) Holdings Limited]